
Molly Gibson, PhD
Chief Executive Officer | Co-Founder
Led by pioneers in covalent drug discovery, generative biology, chemoproteomics, and small molecule AI, we are tackling one of the grand challenges of medicine.
Get to know the leaders of our expedition.